glp 1 and depression The GLP-1 semaglutide (#Ozempic) failed to improve mood executive functioning in this, the first RCT of a GLP-1 for major #depression: https://t.co/kWb7ky8Ab2 Weight loss was significant (all subjects were overweight/obese). Evidence Unpacking the Data on GLP-1

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection

The first stall window for tirzepatide users commonly occurs around months 2 to 4, often during the dose escalation phase

Developed by Novo Nordisk, CagriSema is a combination medication of cagrilintide and the GLP-1 receptor agonist semaglutide

Through our nutrition expertise and consumer-centric approach, we identified a need for a new line of products that delivers great taste and functional benefits for GLP-1 users or those otherwise managing their weight, Kristen Stoehr, registered dietitian and Vital Pursuit brand manager, said in September 2024